Discover

DNTH
Dianthus Therapeutics, Inc.
82.37
2 x 61.20
2 x 105.83
bid
ask
-
0.06
0.07%
2 @ 04:00 PM
82.37 +0.00 (0.00%)
Ytd99.88%
1y137.04%
82.13
day range
85.20
32.92
52 week range
115.96
Open82.36Prev Close82.43Low82.13High85.20Mkt Cap4.50B
Vol738.87KAvg Vol799.48KEPS-4.23P/EN/AForward P/E-17.86
Beta0.18Short Ratio15.00Inst. Own127.87%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0550-d Avg103.23200-d Avg82.011yr Est140.80

DNTH News

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
benzinga.com
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Oversold health care stocks Align Technology, Dianthus Therapeutics and Ocular Therapeutix show RSI

This Shopify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
This Shopify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts initiated coverage on PPG, Shopify, Chesapeake Utilities, Global Payments and D

benzinga.com
JP Morgan Initiates Coverage On Dianthus Therapeutics with Overweight Rating, Announces Price Target

JP Morgan analyst Brian Cheng initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Ov

benzinga.com
Citigroup Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $15

Citigroup analyst Samantha Semenkow initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) wit

benzinga.com
Truist Securities Maintains Buy on Dianthus Therapeutics, Raises Price Target to $128

Truist Securities analyst Danielle Brill maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Buy

benzinga.com
HC Wainwright & Co. Maintains Buy on Dianthus Therapeutics, Raises Price Target to $158

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Dianthus Therapeutics (NASDAQ:DN

benzinga.com
Wedbush Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $122

Wedbush analyst Laura Chico maintains Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and r

benzinga.com
Dianthus Therapeutics Q2 EPS $(0.90) Misses $(0.88) Estimate, Sales $761.000K Beat $258.583K Estimat

Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.90) per share which missed the

benzinga.com
Dianthus Therapeutics Announces New Pipeline Candidate, DNTH312 for Autoimmune Disorders; The Compan

DNTH312 is an internally developed bifunctional fusion protein targeting potent inhibition of active

benzinga.com
Evercore ISI Group Maintains Outperform on Dianthus Therapeutics, Raises Price Target to $134

Evercore ISI Group analyst Gavin Clark-Gartner maintains Dianthus Therapeutics (NASDAQ:DNTH) with

Why Is Dianthus Therapeutics Stock Trading Higher On Friday?
benzinga.com
Why Is Dianthus Therapeutics Stock Trading Higher On Friday?

Dianthus reports 75% responder rate for claseprubart in CIDP, while analysts say Sanofi's rilipr

Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says
benzinga.com
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says

Sanofi discontinues Phase 3 riliprubart study for CIDP due to low efficacy. SNY stock ticks up. Read

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy

AutoZone To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga.com
AutoZone To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Tuesday

Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B.

This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
benzinga.com
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Wall Street analysts upgraded CRWD, ALEC, RIVN, SEDG, and DNTH. See what other analysts say about th

Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday
benzinga.com
Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Highe

US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Latham Group, Babcock & Wilcox, B&G Foods And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Latham Group, Babcock & Wilcox, B&G Foods And Other Big Stocks Moving Higher On Wednesday

Dow falls 100 pts, Latham Group Inc (SWIM) rises 25.7%, Babcock & Wilcox Enterprises Inc (BW) ga

The Insider Report: Prepare for the Next Dip Buying Opportunity
benzinga.com
The Insider Report: Prepare for the Next Dip Buying Opportunity

General Motors To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
General Motors To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Friday

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In

benzinga.com
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Se

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company report